Modulators and Poststroke Behavioral Changes

Neuro-pathophysiological conditions like cerebrovascular accident (CVA) or stroke are linked to insufficient blood flow to the brain, which causes cell necrosis, a dynamic and complex event. Stroke ranks third in terms of disability-adjusted life years and this condition is the second major cause of mortality. The cerebral vasculature, an important target of oxi-inflammatory stress-driven biomolecular degradation, is interestingly playing a significant role in the etiology of ischemic brain injury following a cerebrovascular event. Peripheral lymphocytes that enter ischemic areas of the brain coordinate inflammatory reactions, complement cascade, trigger tissue death, and worsen stroke clinical outcomes. Therefore, developing combination therapies that focus on multiple mechanisms or cellular pathways may be more successful than using single therapies alone. Moreover, stroke survivors frequently experience emotional and behavioral changes, which includes irritability, cognitive impairment, disability, inattention, disorientation, and feelings of anger, anxiety, or depression. Despite a plethora of neuroscientific initiatives and therapeutic efforts, several remedial pages are still unfinished and require more significant clinical insight not only to resolve the conundrum of CVA but also to mitigate the burden of stroke. This chapter reviews various types of stroke modulators such as ion channels, transcription factors, receptors, gene modulators, and their metabolic rate. This review also highlights pathophysiologic damage with particular emphasis on poststroke behavioral changes in survivors.